交易 Novavax NVAX

出售
 买入

Novavax 实时图表

5m 15m 30m 1h 4h 1d 1w

金融票据基础知识

Weekly Search
Weekly
Daily
日期 关闭 更改 更改(%)： 开盘价 高 低

Novavax news

2021 五月 11, 13:20

US pre-market: selling unabated

2021 五月 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 五月 26, 08:04

Leg up: stocks make new ground, travel stocks soar

最新新闻

显示更多
Liam James 2025 Aug 22, 15:20

Market Review & Investment Insights: August 2025

Noah Lee 2025 Aug 22, 15:20

Trump Threatens to Fire Fed Governor Lisa Cook Amid Mortgage Fraud Allegations

Liam James 2025 Aug 22, 15:20

Wall Street Reacts: Powell Hints at September Rate Cut, But Cautiously

Liam James 2025 Aug 22, 14:20

Dollar Bullish Sentiment Rises Ahead of Powell Speech, Forex Options Show

Ava Grace 2025 Aug 22, 12:20

Syria to Revalue Currency: Removing Zeros in Bid to Restore Confidence

Noah Lee 2025 Aug 22, 10:20

India, Russia Expand Trade Amid US Tariff Pressure

Ava Grace 2025 Aug 22, 08:20

Trump Administration Eyes Repurposing Chip Act Funds for Critical Minerals

Emma Rose 2025 Aug 22, 08:20

Powell's Jackson Hole Speech: Shaping the Fed's Future Amidst Economic Uncertainty

信息

点差

0.05

点差(%)

0.6394 %

杠杆

1:10

隔夜利息（买入）

-0.0597 %

隔夜利息（卖出）

-0.0292 %

币种

USD

交易时间

市场关闭

星期一

13:31 - 19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期四

13:31-19:59

星期五

13:31-19:59

分析和统计

开盘价

---

昨收

---

52 周高点/低点

--- – ---

市值

1239279872

在外流通股份

162422000

财报日（下一）

2019-05-10

股息收益率

2019-05-10

除息日

远期年度股息率

0

远期年股息率

0

每股收益

2.22

详细了解此金融票据

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

相关金融票据

资产
出售
买入
更改(%)：

立即交易

立即交易

立即交易

立即交易
相关金融票据

latest_education_articles

显示更多
Markets.com Support Team 2024 Nov 29, 03:00

如果你在 2010 年以每枚 $0.10 投資了 $100 的比特幣，今天您的資產將高達驚人的 9,570 萬美元！

Markets.com Support Team 2024 Nov 20, 17:00

狗狗幣的瘋狂旅程

Markets.com Support Team 2024 Nov 08, 17:00

交易員趨勢：狗狗幣

Trustpilot